CoChat
Sign Up
Cited by 25

Intravitreal injection of anti-miRs against miR-142-3p reduces angiogenesis and microglia activation in a mouse model of laser-induced choroidal neovascularization

Roblain, Quentin, Louis, Thomas, Yip, Cassandre, Baudin, Louis, Struman, Ingrid, Caolo, Vincenza, Lambert, Vincent, Lecomte, Julie +2 more·2021·Aging
DOI 10.18632/aging.203035PMC PMC8148470
Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/aging.203035

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • miR-7 regulates neuronal death and glutamatergic signaling; miR-137 is critical for neural development; miR-935 and miR-129-2-3p are elevated in epileptic brains and plasma.

    “miR-7 regulates neuronal death and glutamatergic signaling 40,41 ; miR-137 is critical for neural development 42 ; miR-935 and miR-129-2-3p are both elevated in epileptic brains and plasma 43 .”

    From Human brain microRNAs exhibit cell-type specificity and age dependence (2026) · cites this paper as [40]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 47

  1. [2]Flaxman SR, Bourne RR, Resnikoff S, Ackland P, Braithwaite T, Cicinelli MV, Das A, Jonas JB, Keeffe J, Kempen JH, Leasher J, Limburg H, Naidoo K, et al, and Vision Loss Expert Group of the Global Burden of Disease Study. Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis. Lancet Glob Health. 2017; 5: e1221– 34. 10.1016/S2214-109X(17)30393-5 29032195 · DOI · Paper page
  2. [3]Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, Wong TY. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014; 2: e106– 16. 10.1016/S2214-109X(13)70145-1 25104651 · DOI
  3. [4]Adelman RA, Sigler EJ, Seth RK. Age-related Macular Degeneration—Review and Current Concepts. US Ophthalmic Review. 2011; 04. 10.17925/USOR.2011.04.02.119 · DOI
  4. [5]Storey P, Hark L, Haller JA. Age-Related Macular Degeneration. Handbook of Nutrition, Diet and the Eye. 2014. pp. 11– 20. 10.1016/B978-0-12-401717-7.00002-2 · DOI
  5. [6]Fletcher EL. Contribution of microglia and monocytes to the development and progression of age related macular degeneration. Ophthalmic Physiol Opt. 2020; 40: 128– 39. 10.1111/opo.12671 32017190 · DOI
  6. [7]Lambert V, Lecomte J, Hansen S, Blacher S, Gonzalez ML, Struman I, Sounni NE, Rozet E, de Tullio P, Foidart JM, Rakic JM, Noel A. Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice. Nat Protoc. 2013; 8: 2197– 211. 10.1038/nprot.2013.135 24136346 · DOI
  7. [9]Park YG, Rhu HW, Kang S, Roh YJ. New Approach of Anti-VEGF Agents for Age-Related Macular Degeneration. J Ophthalmol. 2012; 2012: 637316. 10.1155/2012/637316 22496964 PMC3307057 · DOI
  8. [10]Zuber-Laskawiec K, Kubicka-Trzaska A, Karska-Basta I, Pociej-Marciak W, Romanowska-Dixon B. Non-responsiveness and tachyphylaxis to anti-vascular endothelial growth factor treatment in naive patients with exudative age-related macular degeneration. J Physiol Pharmacol. 2019; 70. 10.26402/jpp.2019.5.13 32009630 · DOI
  9. [11]O’Brien J, Hayder H, Zayed Y, Peng C. Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation. Front Endocrinol (Lausanne). 2018; 9: 402. 10.3389/fendo.2018.00402 30123182 PMC6085463 · DOI · Paper page
  10. [12]Gebert LF, MacRae IJ. Regulation of microRNA function in animals. Nat Rev Mol Cell Biol. 2019; 20: 21– 37. 10.1038/s41580-018-0045-7 30108335 PMC6546304 · DOI · Paper page
  11. [13]Bartel DP. Metazoan MicroRNAs. Cell. 2018; 173: 20– 51. 10.1016/j.cell.2018.03.006 29570994 PMC6091663 · DOI · Paper page
  12. [14]Xu S, Hazlett LD. MicroRNAs in Ocular Infection. Microorganisms. 2019; 7: 359. 10.3390/microorganisms7090359 31533211 PMC6780979 · DOI
  13. [15]Raghunath A, Perumal E. Micro-RNAs and their roles in eye disorders. Ophthalmic Res. 2015; 53: 169– 86. 10.1159/000371853 25832915 · DOI
  14. [16]Ménard C, Rezende FA, Miloudi K, Wilson A, Tétreault N, Hardy P, SanGiovanni JP, De Guire V, Sapieha P. MicroRNA signatures in vitreous humour and plasma of patients with exudative AMD. Oncotarget. 2016; 7: 19171– 84. 10.18632/oncotarget.8280 27015561 PMC4991373 · DOI
  15. [17]Kiel C, Berber P, Karlstetter M, Aslanidis A, Strunz T, Langmann T, Grassmann F, Weber BH. A Circulating MicroRNA Profile in a Laser-Induced Mouse Model of Choroidal Neovascularization. Int J Mol Sci. 2020; 21: 2689. 10.3390/ijms21082689 32294914 PMC7216141 · DOI
  16. [18]Liu CH, Huang S, Britton WR, Chen J. MicroRNAs in Vascular Eye Diseases. Int J Mol Sci. 2020; 21: 649. 10.3390/ijms21020649 31963809 PMC7014392 · DOI
  17. [19]Marques-Rocha JL, Samblas M, Milagro FI, Bressan J, Martínez JA, Marti A. Noncoding RNAs, cytokines, and inflammation-related diseases. FASEB J. 2015; 29: 3595– 611. 10.1096/fj.14-260323 26065857 · DOI
  18. [20]Tiwari A, Mukherjee B, Dixit M. MicroRNA Key to Angiogenesis Regulation: MiRNA Biology and Therapy. Curr Cancer Drug Targets. 2018; 18: 266– 77. 10.2174/1568009617666170630142725 28669338 · DOI
  19. [21]Rakic JM, Lambert V, Munaut C, Bajou K, Peyrollier K, Alvarez-Gonzalez ML, Carmeliet P, Foidart JM, Noël A. Mice without uPA, tPA, or plasminogen genes are resistant to experimental choroidal neovascularization. Invest Ophthalmol Vis Sci. 2003; 44: 1732– 39. 10.1167/iovs.02-0809 12657615 · DOI
  20. [22]Crespo-Garcia S, Reichhart N, Hernandez-Matas C, Zabulis X, Kociok N, Brockmann C, Joussen AM, Strauss O. In vivo analysis of the time and spatial activation pattern of microglia in the retina following laser-induced choroidal neovascularization. Exp Eye Res. 2015; 139: 13– 21. 10.1016/j.exer.2015.07.012 26213305 · DOI
  21. [23]Silverman SM, Wong WT. Microglia in the Retina: Roles in Development, Maturity, and Disease. Annu Rev Vis Sci. 2018; 4: 45– 77. 10.1146/annurev-vision-091517-034425 29852094 · DOI
  22. [24]Bao H, Chen YX, Huang K, Zhuang F, Bao M, Han Y, Chen XH, Shi Q, Yao QP, Qi YX. Platelet-derived microparticles promote endothelial cell proliferation in hypertension via miR-142-3p. FASEB J. 2018; 32: 3912– 23. 10.1096/fj.201701073R 29481306 · DOI
  23. [25]Costa T, Fernandez-Villalba E, Izura V, Lucas-Ochoa AM, Menezes-Filho NJ, Santana RC, de Oliveira MD, Araújo FM, Estrada C, Silva V, Costa SL, Herrero MT. Combined 1-Deoxynojirimycin and Ibuprofen Treatment Decreases Microglial Activation, Phagocytosis and Dopaminergic Degeneration in MPTP-Treated Mice. J Neuroimmune Pharmacol. 2020. [Epub ahead of print]. 10.1007/s11481-020-09925-8 32564332 · DOI
  24. [26]Stankov A, Belakaposka-Srpanova V, Bitoljanu N, Cakar L, Cakar Z, Rosoklija G. Visualisation of Microglia with the use of Immunohistochemical Double Staining Method for CD-68 and Iba-1 of Cerebral Tissue Samples in Cases of Brain Contusions. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2015; 36: 141– 45. 10.1515/prilozi-2015-0062 27442380 · DOI
  25. [27]Hernández S, Lloreta J. Manual versus laser micro-dissection in molecular biology. Ultrastruct Pathol. 2006; 30: 221– 28. 10.1080/01913120500521018 16825124 · DOI
  26. [28]Grassmann F, Schoenberger PG, Brandl C, Schick T, Hasler D, Meister G, Fleckenstein M, Lindner M, Helbig H, Fauser S, Weber BH. A circulating microrna profile is associated with late-stage neovascular age-related macular degeneration. PLoS One. 2014; 9: e107461. 10.1371/journal.pone.0107461 25203061 PMC4159338 · DOI
  27. [29]Zhang L, Liu S, Wang JH, Zou J, Zeng H, Zhao H, Zhang B, He Y, Shi J, Yoshida S, Zhou Y. Differential Expressions of microRNAs and Transfer RNA-derived Small RNAs: Potential Targets of Choroidal Neovascularization. Curr Eye Res. 2019; 44: 1226– 35. 10.1080/02713683.2019.1625407 31136199 · DOI
  28. [30]Du X, Hong L, Sun L, Sang H, Qian A, Li W, Zhuang H, Liang H, Song D, Li C, Wang W, Li X. miR-21 induces endothelial progenitor cells proliferation and angiogenesis via targeting FASLG and is a potential prognostic marker in deep venous thrombosis. J Transl Med. 2019; 17: 270. 10.1186/s12967-019-2015-z 31416448 PMC6694687 · DOI
  29. [31]Fan B, Jin Y, Zhang H, Zhao R, Sun M, Sun M, Yuan X, Wang W, Wang X, Chen Z, Liu W, Yu N, Wang Q, et al. MicroRNA-21 contributes to renal cell carcinoma cell invasiveness and angiogenesis via the PDCD4/c-Jun (AP-1) signalling pathway. Int J Oncol. 2020; 56: 178– 92. 10.3892/ijo.2019.4928 31789394 PMC6910186 · DOI
  30. [32]Walz JM, Wecker T, Zhang PP, Cakir B, Gruening B, Agostini H, Reuer T, Ludwig F, Boneva S, Faerber L, Lange C, Schlunck GR, Stahl A. Impact of angiogenic activation and inhibition on miRNA profiles of human retinal endothelial cells. Exp Eye Res. 2019; 181: 98– 104. 10.1016/j.exer.2019.01.006 30615884 · DOI
  31. [33]Romano GL, Platania CB, Drago F, Salomone S, Ragusa M, Barbagallo C, Di Pietro C, Purrello M, Reibaldi M, Avitabile T, Longo A, Bucolo C. Retinal and Circulating miRNAs in Age-Related Macular Degeneration: An In vivo Animal and Human Study. Front Pharmacol. 2017; 8: 168. 10.3389/fphar.2017.00168 28424619 PMC5371655 · DOI
  32. [34]Tong N, Jin R, Zhou Z, Wu X. Involvement of microRNA-34a in Age-Related Susceptibility to Oxidative Stress in ARPE-19 Cells by Targeting the Silent Mating Type Information Regulation 2 Homolog 1/p66shc Pathway: Implications for Age-Related Macular Degeneration. Front Aging Neurosci. 2019; 11: 137. 10.3389/fnagi.2019.00137 31249522 PMC6584679 · DOI · Paper page
  33. [35]Shrestha A, Mukhametshina RT, Taghizadeh S, Vásquez-Pacheco E, Cabrera-Fuentes H, Rizvanov A, Mari B, Carraro G, Bellusci S. MicroRNA-142 is a multifaceted regulator in organogenesis, homeostasis, and disease. Dev Dyn. 2017; 246: 285– 90. 10.1002/dvdy.24477 27884048 · DOI
  34. [36]Mandolesi G, De Vito F, Musella A, Gentile A, Bullitta S, Fresegna D, Sepman H, Di Sanza C, Haji N, Mori F, Buttari F, Perlas E, Ciotti MT, et al. miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation. J Neurosci. 2017; 37: 546– 61. 10.1523/JNEUROSCI.0851-16.2016 28100738 PMC6596761 · DOI
  35. [37]Huang P, Sun J, Wang F, Luo X, Feng J, Gu Q, Liu T, Sun X. MicroRNA Expression Patterns Involved in Amyloid Beta-Induced Retinal Degeneration. Invest Ophthalmol Vis Sci. 2017; 58: 1726– 35. 10.1167/iovs.16-20043 28324113 · DOI
  36. [38]Chaudhuri AD, Yelamanchili SV, Marcondes MC, Fox HS. Up-regulation of microRNA-142 in simian immunodeficiency virus encephalitis leads to repression of sirtuin1. FASEB J. 2013; 27: 3720– 29. 10.1096/fj.13-232678 23752207 PMC3752547 · DOI · Paper page
  37. [39]Carofino BL, Dinshaw KM, Ho PY, Cataisson C, Michalowski AM, Ryscavage A, Alkhas A, Wong NW, Koparde V, Yuspa SH. Head and neck squamous cancer progression is marked by CLIC4 attenuation in tumor epithelium and reciprocal stromal upregulation of miR-142-3p, a novel post-transcriptional regulator of CLIC4. Oncotarget. 2019; 10: 7251– 75. 10.18632/oncotarget.27387 31921386 PMC6944452 · DOI
  38. [40]Guiot J, Cambier M, Boeckx A, Henket M, Nivelles O, Gester F, Louis E, Malaise M, Dequiedt F, Louis R, Struman I, Njock MS. Macrophage-derived exosomes attenuate fibrosis in airway epithelial cells through delivery of antifibrotic miR-142-3p. Thorax. 2020; 75: 870– 81. 10.1136/thoraxjnl-2019-214077 32759383 PMC7509395 · DOI
  39. [41]Ba J, Peng RS, Xu D, Li YH, Shi H, Wang Q, Yu J. Intravitreal anti-VEGF injections for treating wet age-related macular degeneration: a systematic review and meta-analysis. Drug Des Devel Ther. 2015; 9: 5397– 405. 10.2147/DDDT.S86269 26451092 PMC4592052 · DOI
  40. [42]Young K, Morrison H. Quantifying Microglia Morphology from Photomicrographs of Immunohistochemistry Prepared Tissue Using ImageJ. J Vis Exp. 2018; 57648. 10.3791/57648 29939190 PMC6103256 · DOI
  41. [43]Damani MR, Zhao L, Fontainhas AM, Amaral J, Fariss RN, Wong WT. Age-related alterations in the dynamic behavior of microglia. Aging Cell. 2011; 10: 263– 76. 10.1111/j.1474-9726.2010.00660.x 21108733 PMC3056927 · DOI · Paper page
  42. [44]Zanier ER, Fumagalli S, Perego C, Pischiutta F, De Simoni MG. Shape descriptors of the ”never resting“ microglia in three different acute brain injury models in mice. Intensive Care Med Exp. 2015; 3: 39. 10.1186/s40635-015-0039-0 26215806 PMC4513020 · DOI · Paper page
  43. [46]Kwak N, Okamoto N, Wood JM, Campochiaro PA. VEGF is major stimulator in model of choroidal neovascularization. Invest Ophthalmol Vis Sci. 2000; 41: 3158– 64. 10967078
  44. [47]Huang H, Parlier R, Shen JK, Lutty GA, Vinores SA. VEGF receptor blockade markedly reduces retinal microglia/macrophage infiltration into laser-induced CNV. PLoS One. 2013; 8: e71808. 10.1371/journal.pone.0071808 23977149 PMC3748119 · DOI
  45. [48]Martínez Leo EE, Segura Campos MR. Neuroprotective effect from Salvia hispanica peptide fractions on pro-inflammatory modulation of HMC3 microglial cells. J Food Biochem. 2020; 44: e13207. 10.1111/jfbc.13207 32207175 · DOI
  46. [49]Cappoli N, Mezzogori D, Tabolacci E, Coletta I, Navarra P, Pani G, Dello Russo C. The mTOR kinase inhibitor rapamycin enhances the expression and release of pro-inflammatory cytokine interleukin 6 modulating the activation of human microglial cells. EXCLI J. 2019; 18: 779– 98. 10.17179/excli2019-1715 31645839 PMC6806201 · DOI
  47. [50]Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez JY, White DJ, Hartenstein V, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012; 9: 676– 82. 10.1038/nmeth.2019 22743772 PMC3855844 · DOI · Paper page

Cited by

Sorted by citations

Authors
Roblain, Q., Louis, T., Yip, C., Baudin, L., Struman, I., Caolo, V., Lambert, V., Lecomte, J., Noël, A., & Heymans, S.
Affiliations
  • Laboratory of Tumor and Development Biology, GIGA-Cancer, University of Liège, Liège, Belgium
  • Molecular Angiogenesis Laboratory, GIGA-Cancer, University of Liège, Liège, Belgium
  • Department of Cardiovascular Sciences, Centre for Molecular and Vascular Biology, KU Leuven, Leuven, Belgium
  • Department of Cardiology, CARIM School for Cardiovascular Diseases, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands
Venue
Aging
Publisher
Impact Journals, LLC
Published
2021-05-05
Volume
13
Issue
9
Pages
12359-12377
ISSN
1945-4589
DOI
10.18632/aging.203035
PMC
PMC8148470
Cited by
25
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review